“…Yong et al[113] synthesized 3′-spirocyclic-oxindole compounds, based on the Spiro[indole-3,5′-isoxazolidin]-2(1H)-one, the 2′H-spiro [indole-3,6′-[1,3]oxazinane] -2,2′(1H)-dione and the 2′H-spiro[indoline-3,3′-pyrrolo[1,2c][1,3′]oxazine]-1′,2(1H)-dione heterocyclic compounds (32-34). These compounds were prepared from methyl α-(2-nitrophenyl)acrylate via[1,3]dipolar cycloaddition reactions with two acyclic nitrones and one cyclic nitrone followed by reduction of the cycloadducts and then treatment with triphosgene. Two of these compounds showed significant cytostatic activity on three cancer cell lines with GI50 values of 2.6-4.1 μM on the human breast cancer cell line, MCF-7.Barakat et al[114] investigated one-pot three-component reaction via a[3 + 2] cycloaddition/ring contraction sequence of a dipolarophile (activated alkene) with in situ-generated azomethine ylide (1,3-dipoles) without the use of any catalyst leading to the formation of biologically important spirooxindoles in high yield (69-94%) with high diastereoselectivity.…”